BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 13, 2011
View Archived Issues
S-44563 assessed in vivo in models of uveal melanoma
Read More
Full results reported from phase II trial of aldosterone synthase inhibitor in primary hypertension
Read More
Promising in vivo data presented on BI-853520
Read More
Mutant-selective inhibitor of epidermal growth factor receptor assessed in NSCLC
Read More
Boehringer Ingelheim discloses preclinical data on MAb targeting insulin-like growth factor I and II
Read More
Lilly describes antitumor effects of dual cyclin-dependent kinase inhibitor
Read More
Cel-Sci updates status of phase III Multikine trial
Read More
Immunomedics provides overview of development activities 2011
Read More
Hand, foot and mouth disease vaccine is safe and immunogenic
Read More
Sanofi discloses new histamine H3 receptor inverse agonists
Read More
Janssen begins phase II CNTO-1959 trial with milestone payment to MorphoSys
Read More
Novel phosphodiesterase 10A inhibitors synthesized by Amgen
Read More
Fuso withdraws Japanese application for buprenorphine buccal adhesive
Read More
Theravance begins proof-of-concept study of new candidate ADHD therapy
Read More
Kissei to transfer distribution rights for Parkinson's disease treatment
Read More
European Commission approves product for CDI-associated diarrhea
Read More
Health Canada approves treatment for iron deficiency anemia in CKD
Read More
Medical Research Council Technology patents novel protein kinase inhibitors
Read More
Data and safety monitoring board recommends continuation of vosaroxin trial
Read More
Abbott and Reata Pharmaceuticals enter new collaboration agreement
Read More
Ono and Receptos join to discover novel GPCR-targeted therapeutics
Read More
Mochida out-licenses type 2 diabetes treatment candidates
Read More
Dako collaborates with Genentech on companion diagnostics for pertuzumab
Read More
First Nanobody for inhalation enters clinic
Read More
NIDA to fund study of Biotie's nepicastat
Read More